A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging

The protozoan Trypanosoma cruzi is the causative agent of Chagas disease, one of the world’s major neglected infections. Although development of improved antiparasitic drugs is considered a priority, there have been no significant treatment advances in the past 40 years. Factors that have limited pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Michael D., Francisco, Amanda Fortes, Taylor, Martin C., Kelly, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361455/
https://www.ncbi.nlm.nih.gov/pubmed/25296657
http://dx.doi.org/10.1177/1087057114552623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361455/
https://www.ncbi.nlm.nih.gov/pubmed/25296657
http://dx.doi.org/10.1177/1087057114552623

Ejemplares similares